Related Experiment Video
Updated: Jul 2, 2025

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles.
Xiao Cheng1,2, Brian S Henick3, Ke Cheng4
1Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Cancer cells release extracellular vesicles (EVs) that drive tumor growth and metastasis. Targeting these cancer-derived EVs offers new therapeutic strategies for improving patient outcomes.
Area of Science:
- Oncology
- Cell Biology
- Nanotechnology
Background:
- Extracellular vesicles (EVs) are natural nanoparticles secreted by cells.
- Cancer-derived EVs promote tumor progression, metastasis, and immune evasion.
- Current research explores targeting EVs for cancer therapy.
Purpose of the Study:
- To summarize the origin and functions of cancer-derived EVs.
- To review recent advancements in targeting cancer EVs for therapeutic strategies.
Main Methods:
- Literature review of cancer-derived EV functions.
- Analysis of therapeutic strategies targeting EVs.
- Exploration of EV engineering for anticancer applications.
Main Results:
- Cancer EVs facilitate tumor growth, invasion, and metastasis.
- Strategies include inhibiting EV production, disrupting trafficking, and blocking uptake.
- EV engineering shows potential for developing EV-based anticancer agents.
Conclusions:
- Cancer-derived EVs play a critical role in malignant progression.
- Targeting EVs represents a promising avenue for novel cancer therapies.
- EV engineering offers innovative approaches to harness EVs as therapeutic tools.
More Related Videos
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Cell Migration through Invadopodia
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...